NCT05052528 2024-05-13Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaUniversity of California, DavisPhase 1 Unknown36 enrolled